BillionToOne snaps up $125m Series C
BillionToOne, Inc., a next-generation molecular diagnostics company, has raised $125 million in Series C funding.
BillionToOne, Inc., a next-generation molecular diagnostics company, has raised $125 million in Series C funding.
Copyright PEI Media
Not for publication, email or dissemination